Cargando…
Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction
BACKGROUND: Lipoatrophy and/or central fat gain are observed frequently in patients on antiretroviral therapy (ART). Both are assumed to be antiretroviral adverse drug reactions. METHODS: We conducted a systematic review to determine whether fat loss or gain was more common in HIV-infected patients...
Autores principales: | de Waal, Reneé, Cohen, Karen, Maartens, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665842/ https://www.ncbi.nlm.nih.gov/pubmed/23723990 http://dx.doi.org/10.1371/journal.pone.0063623 |
Ejemplares similares
-
Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts
por: de Waal, Reneé, et al.
Publicado: (2018) -
First-line antiretroviral drug discontinuations in children
por: Fortuin-de Smidt, Melony, et al.
Publicado: (2017) -
The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings
por: Abrahams, Zulfa, et al.
Publicado: (2014) -
Lipoatrophy/lipohypertrophy outcomes after antiretroviral therapy switch in children in the UK/Ireland
por: Innes, Steve, et al.
Publicado: (2018) -
Additional attention to combination antiretroviral therapy-related lipodystrophy
por: Kobayashi, Norihiko, et al.
Publicado: (2017)